Cardiff Oncology, Inc.
CRDF
Revenue
163.00k
▼-42.00k▼-20.49%
3 Months ChangeAssets
66.05M
▼-7.99M▼-10.79%
3 Months ChangeLiabilities
13.66M
▲519.00k▲3.95%
3 Months ChangeFree Cash Flow
-7.82M
▲847.00k▲9.77%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 8-K
ID: 0001628280-24-036122
2024-08-08
Form 10-Q
ID: 0001628280-24-036098
2024-06-20
Form 8-K
ID: 0001628280-24-029108
2024-06-03
Form 8-K
ID: 0001628280-24-026295
2024-05-02
Form 8-K
ID: 0001628280-24-020010
2024-05-02
Form 10-Q
ID: 0001628280-24-019974
2024-04-08
Form 8-K
ID: 0001628280-24-015247
2024-02-29
Form 8-K
ID: 0001628280-24-007972
2024-01-08
Form 8-K
ID: 0001628280-24-000780
2023-11-02
Form 8-K
ID: 0001628280-23-036386